Latest pharmaceutical reputation study praises AbbVie, Novo and Takeda
A study, conducted by Boston-based Reputation Institute, collated more than 16,500 reputation ratings collected throughout the U.S., Europe and Brazil during first two months of this year has ranked AbbVie No. 1. Who is then closely followed by Novo Nordisk and Takeda, who edged out rivals from a group of 17 companies to earn spots